文献速递肺外科

五种肺叶切除术各自的风险:胸外科医师学会数据库分析

Risk of Each of the Five Lung Lobectomies: A Society of Thoracic Surgeons Database Analysis.
PubMed 文献 · Ann Thorac Surg · 2022-03-24

基于胸外科医师学会数据库2008至2018年65006例肺叶切除术患者,分析各肺叶切除的围手术期结局。右中叶切除调整后死亡率、主要并发症率和输血率均最低,右下肢切除死亡率最高,右上叶和右下肢主要并发症率最高。不同肺叶切除术后结局存在明显差异。

要点

  • 右中叶切除调整后死亡率0.63%,为五叶中最低。
  • 右下肢切除调整后死亡率1.63%,为五叶中最高。
  • 右上叶和右下肢主要并发症率最高,为8.94%至9.32%。

核心结论

  • 肺叶切除术后结局因切除肺叶位置不同而存在明显差异,右中叶切除的死亡率、主要并发症率和输血率最低,但其他肺叶间存在差异。

研究设计与样本

  • 查询胸外科医师学会数据库2008年至2018年接受肺叶切除术的患者,分析患者与疾病特征、手术变量、主要并发症和30天死亡率,并采用多变量逻辑回归模型(使用当前胸外科医师学会肺叶切除风险模型中的相同变量)评估切除部位对不良结局的贡献。

主要发现

  • 共分析65006例患者,调整后围手术期死亡率右中叶最低为0.63%,右上叶、左上叶和左下叶居中为1.08%至1.24%,右下叶最高为1.63%。
  • 调整后主要并发症率右中叶最低为5.36%,左下叶和左上叶居中为7.82%至8.33%,右上叶和右下叶最高为8.94%至9.32%。
  • 调整后术中输血率右中叶最低为1.37%,右下叶和左下叶居中为1.81%至1.94%,右上叶和左上叶最高为2.47%至2.72%。

临床怎么用

  • 作者认为这些差异应在评估手术风险、决定最佳治疗、患者咨询和比较结局时予以认识。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The perioperative risk of pulmonary lobectomy as a solitary procedure has been extensively studied, yet the differences in outcomes between lobes, which have unique anatomy and a different amount of lung parenchyma, are entirely unknown. The purpose of this study was to define the risk of each of the 5 lobectomies. METHODS: The Society of Thoracic Surgeons Database was queried for patients undergoing lobectomy between 2008 and 2018. Patient and disease characteristics, operative variables, major morbidity, and 30-day mortality were examined. A multivariable logistic regression model (using the same variables in the current Society of Thoracic Surgeons lobectomy risk model) was developed to assess the contribution of lobectomy site to adverse outcomes. RESULTS: There were 65 006 patients analyzed. Adjusted perioperative mortality rate is lowest for right middle lobe (RML), 0.63%; intermediate for right upper lobe (RUL), left upper lobe (LUL), and left lower lobe (LLL), 1.08 to 1.24%; and highest for right lower lobe (RLL), 1.63%. The adjusted major morbidity rate is lowest for RML, 5.36%; intermediate for LLL and LUL, 7.82% to 8.33%; and highest for RUL and RLL, 8.94% to 9.32%. Adjusted intraoperative transfusion rate is lowest for RML, 1.37%; intermediate for RLL and LLL, 1.81% to 1.94%; and highest for RUL and LUL, 2.47% to 2.72%. CONCLUSIONS: There are clear differences in postoperative outcomes by lobectomy location. Mortality, major morbidity, and transfusion rate are lowest for RML but vary across other lobectomies. These differences should be appreciated in evaluating risk of operation, deciding on best therapy, counseling patients, and comparing outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Linden PA, Block MI, Perry Y, et al. Risk of Each of the Five Lung Lobectomies: A Society of Thoracic Surgeons Database Analysis. Ann Thorac Surg. 2022. PMID: 35339439. doi:10.1016/j.athoracsur.2022.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。